Skip to main content
Clinical Trials/NCT02584036
NCT02584036
Completed
Not Applicable

Project IMPACT Immunizations (IMProving America's Communities Together)

American Pharmacists Association Foundation8 sites in 1 country1,080 target enrollmentOctober 2015
ConditionsInfluenza

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Influenza
Sponsor
American Pharmacists Association Foundation
Enrollment
1080
Locations
8
Primary Endpoint
Number of times the pharmacist reviewed the vaccination forecast and educated the patient on his/her vaccine needs
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The primary objective of this study is to evaluate how implementing an innovative care model that provides the pharmacist access to a patient's vaccine history at the point-of-care impacts the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations.

Detailed Description

This is a multi-site, observational study investigating the impact of implementing an innovative care model on the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations. The innovative care model enables the pharmacist to utilize a bi-directional IIS to assess patients' vaccination histories, identify unmet vaccination needs, and document the care provided. Data will be collected in the bi-directional IIS. Aggregate de-identified data will be reported to the researchers at the midpoint and conclusion of the study. The project duration has been established to allow sufficient time for each pharmacy to implement the innovative care model and monitor each pharmacy for a 6-month study period. The American Pharmacists Association (APhA) Foundation has an a priori intent to publish the project results.

Registry
clinicaltrials.gov
Start Date
October 2015
End Date
July 2016
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Individuals eligible to be enrolled in the study include any person at least 18 years of age receiving an influenza vaccination from a participating pharmacy site.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Number of times the pharmacist reviewed the vaccination forecast and educated the patient on his/her vaccine needs

Time Frame: through study completion, an average of 6 months

Number and types of vaccines administered

Time Frame: Change from baseline rates at 6 months

Number of unmet vaccination needs identified and met

Time Frame: through study completion, an average of 6 months

Study Sites (8)

Loading locations...

Similar Trials